Literature DB >> 22523463

Evolutionarily conserved essential genes from arctic bacteria: a tool for vaccination.

Mm Shanmugam1, S Parasuraman.   

Abstract

Entities:  

Year:  2012        PMID: 22523463      PMCID: PMC3326785          DOI: 10.4103/0975-1483.93569

Source DB:  PubMed          Journal:  J Young Pharm        ISSN: 0975-1483


× No keyword cloud information.
Sir, Due to advancement in various molecular biological techniques, several indispensable evolutionarily conserved essential genes (genes that are necessary for viability of the living organisms) have been identified over the past decades among various groups of bacteria.[1-3] Moreover, the amino acid sequences of some of these essential genes were highly conserved across various classes of bacteria such as thermophiles (heat-loving) and psychrophiles (cold-loving). However, some of the product of essential genes of psychrophiles have been adapted to the cold environments for millions to billions of years[4-6] thus making these bacteria temperature-sensitive (TS), reduced viability at higher temperatures. In accordance with the above mentioned facts, the human body temperature varies depending upon the body parts, temperature of the skin varies between 32 and 36°C whereas the body core is about 37–42°C.[78] Over decades, attempts have been made to develop TS bacterial strains and viral strains,[9-12] yet bacterial strains were not adapted for human vaccination,[13] for example, the TS version of Yersinia pestis[14] and because of their reversion this strain was not further developed.[13] Further, small numbers of TS bacterial strain vaccines (developed by chemical mutagenesis) were developed for veterinary use; but it is uncertain whether the TS nature is primary attenuating phenotype or merely a coincidental phenotype.[13] In the following work, Duplantis and colleagues have successfully transformed mesophilic pathogenic bacteria to a TS bacterial strain using essential genes from psychrophile and provide evidences for a successful vaccination strategy developed using such TS bacterial strain. The highlight, in the following work, is provided by the concept of using temperature adapted essential orthologue genes from psychrophile to develop the TS non-pathogenic version of bacterial strains. In this study, the authors chose pathogenic mesophile Francisella tularensis subsp. novicida (F. novicida), maximum growth temperature is about 45°C, as host to transfer essential genes from a psychrophile Colwellia psychrerythraea, maximum growth temperature is about 19°C. Strains of F. tularensis is highly virulent to mice but also known to cause zoonotic disease in humans.[15] Here, the selection of host and donor species was based on the similar G + C contents of these species.[1617] In order to maximize the chance that the foreign gene is expressed identically to the homolog that it replaced, the authors engineered the foreign psychrophilic gene under the control of a host promoter and expressed it using host machinery [Figure 1]. The rate of mutation that will revert back the TS strain to a temperature-resistant strain was also assessed by the authors on essential gene such as ligA, ligA, ligA, hemC, pyrG, dnaK, murG, dnaK, fmt, ftsZ, cmk, and tyrS.[18]
Figure 1

Flowchart representing the transfer of essential gene from a psychrophilic bacterium to a mesophilic bacterium resulting in formation of temperature sensitive mesophilic host bacterium

Flowchart representing the transfer of essential gene from a psychrophilic bacterium to a mesophilic bacterium resulting in formation of temperature sensitive mesophilic host bacterium To check the TS viability of the TS F. novicida carrying either ligA, ligA or dnaK essential genes, the strains were broth cultured at restrictive temperatures. Results showed an identical growth rate to that of wild-type F. novicida. Since F. novicida is a facultative intracellular pathogen, the growth rate of TS F. novicida in infected macrophages-like cell line (J774 cell line) was examined to check the TS viability. The results showed a decline in the number of viable TS F. novicida in the J774 cell line at restrictive temperature, indicating the temperature sensitivity of TS F. novicida carrying either ligA, ligA and dnaK essential genes. Moreover, TS F. novicida carrying either ligA or ligA showed a growth rate similar to wild-type F. novicida at permissive temperatures within infected J774 cells, whereas strain carrying dnaK showed a poor growth indicating the gene-specific variability among the TS strains created.[18] To determine the pathogenic effect caused by TS F. novicida on infected cultured J774 cells, the cells were microscopically examined for their viability. It was found that the J774 cell infected with TS F. novicida remained viable on shifting to restrictive temperature when compared to control (J774 cells infected with wild-type F. novicida), indicating the nonpathogenic nature of engineered TS F. novicida strains.[18] In order to test the capacity of TS F. novicida to grow only in cooler body regions and not in warmer body core, rats and mice were infected with the TS F. novicida at the base of tail. It was observed that TS F. novicida with restrictive temperatures at or below 37°C were not found in spleen whereas F. novicida with restrictive temperature above 37°C were detected in spleen (control), indicating the inefficiency of TS F. novicida strains to proliferate at body core organs. Moreover, viable TS F. novicida were found at the site of infection even after 3 days of injection, indicating the capacity of TS F. novicida to survive at cool body parts. These results were further validated by injecting the TS F. novicida into the fleshy part of mouse ears.[18] To check whether the persistence of TS F. novicida at cool body parts induce protective immunity, mice were challenged with intranasal infection of wild-type F. novicida after 21 days of vaccination (injection of TS F. novicida carrying either ligA or dnaK) at the base of the tail. Using organ bacterial burden, morbidity and weight loss as measures of protection, it was found that TS F. novicida protected the host animal against the challenge caused by wild-type F. novicida [Figure 2]. It was also found that strains carrying dnaK showed greater dissemination and least protection, indicating the null role of dissemination in immune stimulation.[18]
Figure 2

Flowchart indicating the process of vaccination and subsequent protection against wild-type F. novicida (lane 2) in mouse, whereas showing more organ burden caused in non-vaccinated mouse (lane 1), due to infection with wild-type F. novicida.

Flowchart indicating the process of vaccination and subsequent protection against wild-type F. novicida (lane 2) in mouse, whereas showing more organ burden caused in non-vaccinated mouse (lane 1), due to infection with wild-type F. novicida. Furthermore the effect of psychrophilic ligA was also examined in another Gram-negative bacterium, Salmonella enterica. It was found that psychrophilic ligA rendered the organism TS, indicating that this methodology can be applied to numerous important pathogens such as Salmonella thyphi, Escherichia coli, Yersinia pestis etc. Moreover, a codon-optimized version of ligA (deleting most of the ligA) also made Mycobacterium smegmatis TS, indicating the functional ability of ligA product in a Gram-positive lineage bacterium.[18] The technology described in this work by the authors holds good not only to make live TS bacterial vaccines (known to be efficacious for protection against diseases that need cell-mediated immunity) but also in development of killed whole-cell or subunit vaccine and in development of TS version of dangerous bacterial pathogens which can be used to study their biochemical and pathological characteristics without physical containments.[18] Eventhough the Mother Nature has provided with hundreds of evolutionary conserved essential genes, careful selection of the essential gene from psychrophilic species is required to prevent the transformation of genetically engineered TS strains back to temperature-resistant strains through mutations. Technology developed by Duplantis et al. provides the way for engineering other pathogenic bacteria, so that they can be used as vaccines. However successful clinical trials, using TS bacterial strain for protection against bacterial pathogens, and experimentation will provide the way for the use of this technology for the welfare of humanity.
  18 in total

1.  Cold-adapted genetic variants of polio viruses.

Authors:  M CHAPIN; G R DUBES
Journal:  Science       Date:  1956-09-28       Impact factor: 47.728

Review 2.  A perspective on cold enzymes: current knowledge and frequently asked questions.

Authors:  J C Marx; V Blaise; T Collins; S D'Amico; D Delille; E Gratia; A Hoyoux; A L Huston; G Sonan; G Feller; C Gerday
Journal:  Cell Mol Biol (Noisy-le-grand)       Date:  2004-07       Impact factor: 1.770

3.  The psychrophilic lifestyle as revealed by the genome sequence of Colwellia psychrerythraea 34H through genomic and proteomic analyses.

Authors:  Barbara A Methé; Karen E Nelson; Jody W Deming; Bahram Momen; Eugene Melamud; Xijun Zhang; John Moult; Ramana Madupu; William C Nelson; Robert J Dodson; Lauren M Brinkac; Sean C Daugherty; Anthony S Durkin; Robert T DeBoy; James F Kolonay; Steven A Sullivan; Liwei Zhou; Tanja M Davidsen; Martin Wu; Adrienne L Huston; Matthew Lewis; Bruce Weaver; Janice F Weidman; Hoda Khouri; Terry R Utterback; Tamara V Feldblyum; Claire M Fraser
Journal:  Proc Natl Acad Sci U S A       Date:  2005-07-25       Impact factor: 11.205

Review 4.  Heat regulation: homeostasis of central temperature in man.

Authors:  T H Benzinger
Journal:  Physiol Rev       Date:  1969-10       Impact factor: 37.312

Review 5.  Development and characterization of cold-adapted viruses for use as live virus vaccines.

Authors:  H F Maassab; D C DeBorde
Journal:  Vaccine       Date:  1985-12       Impact factor: 3.641

6.  Live attenuated versus inactivated influenza vaccine in infants and young children.

Authors:  Robert B Belshe; Kathryn M Edwards; Timo Vesikari; Steven V Black; Robert E Walker; Micki Hultquist; George Kemble; Edward M Connor
Journal:  N Engl J Med       Date:  2007-02-15       Impact factor: 91.245

7.  The complete genome sequence of Francisella tularensis, the causative agent of tularemia.

Authors:  Pär Larsson; Petra C F Oyston; Patrick Chain; May C Chu; Melanie Duffield; Hans-Henrik Fuxelius; Emilio Garcia; Greger Hälltorp; Daniel Johansson; Karen E Isherwood; Peter D Karp; Eva Larsson; Ying Liu; Stephen Michell; Joann Prior; Richard Prior; Stephanie Malfatti; Anders Sjöstedt; Kerstin Svensson; Nick Thompson; Lisa Vergez; Jonathan K Wagg; Brendan W Wren; Luther E Lindler; Siv G E Andersson; Mats Forsman; Richard W Titball
Journal:  Nat Genet       Date:  2005-01-09       Impact factor: 38.330

8.  No effect of skin temperature on human ventilation response to hypercapnia during light exercise with a normothermic core temperature.

Authors:  Jesse G Greiner; Miriam E Clegg; Michael L Walsh; Matthew D White
Journal:  Eur J Appl Physiol       Date:  2010-01-20       Impact factor: 3.078

Review 9.  Francisella tularensis: unravelling the secrets of an intracellular pathogen.

Authors:  Petra C F Oyston
Journal:  J Med Microbiol       Date:  2008-08       Impact factor: 2.472

10.  Relationship between bacterial virulence and nucleotide metabolism: a mutation in the adenylate kinase gene renders Yersinia pestis avirulent.

Authors:  Hélène Munier-Lehmann; Viviane Chenal-Francisque; Mihaela Ionescu; Petya Chrisova; Jeannine Foulon; Elisabeth Carniel; Octavian Bârzu
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.